Article

Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients.

University Department of Psychiatry, Sheffield, United Kingdom.
Biological Psychiatry (Impact Factor: 9.25). 03/1998; 43(5):315-9.
Source: PubMed

ABSTRACT It has been hypothesized that depletion of cell membrane n3 polyunsaturated fatty acids (PUFA), particularly docosahexanoic acid (DHA), may be of etiological importance in depression.
We measured the fatty acid composition of phospholipid in cell membranes from red blood cells (RBC) of 15 depressive patients and 15 healthy control subjects.
Depressive patients showed significant depletions of total n3 PUFA and particularly DHA. Incubation of RBC from control subjects with hydrogen peroxide abolished all significant differences between patients and controls.
These findings suggest that RBC membranes in depressive patients show evidence of oxidative damage. Possible interpretations, and implications for the etiology and treatment of depression, are discussed.

0 0
 · 
1 Bookmark
 · 
110 Views
  • [show abstract] [hide abstract]
    ABSTRACT: Xiaochaihutang (XCHT) has been used in China for thousands of years to treat "Shaoyang syndrome", which involves depressive-like symptoms. However, few studies have investigated its antidepressant effects and pharmacological mechanism of action. The present study was designed to confirm the antidepressant effect of XCHT using a chronic unpredictable mild stress (CUMS) model and explore its potential mechanism of action by investigating the monoamine neurotransmitters (Dopamine and 5-hydroxytryptamine) and neurotrophins (BDNF and NGF). The CUMS model was established in rats, and the antidepressant effect of XCHT (0.6, 1.7 and 5mg/kg/day, given by gastric gavage for four weeks) was investigated using the open field test (OFT), food consumption test and sucrose preference test. The concentrations of 5-HT and DA in the hippocampus were measured by high performance liquid chromatography with electrochemical detection (HPLC-ECD). The expressions of brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), and their receptors tyrosine receptor kinase B (TrkB) and tyrosine receptor kinase A (TrkA) in the hippocampus were measured by immunohistochemical staining analysis. CUMS caused a significant decrease in OFT, food consumption and sucrose preference in rats, and these depression-like behaviors were significantly improved by XCHT (1.7 and 5g/kg/day). Moreover, XCHT significantly increased the concentrations of 5-HT (0.6 and 5g/kg/day) and DA (5g/kg/day), and improved the BDNF, NGF, TrkB and TrkA expression in the hippocampus (1.7 and 5g/kg/day), which was reduced in CUMS rats. The results obtained suggested that XCHT may have therapeutic actions on depression-like behavior induced by CUMS in rats possibly mediated by increasing the monoamine neurotransmitter concentration and neurotrophin expression in the hippocampus.
    Journal of ethnopharmacology 01/2014; · 2.32 Impact Factor
  • Source
    [show abstract] [hide abstract]
    ABSTRACT: Background: Depression is a frequent mental disorder characterized by a high level of morbidity in both men and women and has become a leading cause of disability as measured by Years Lived with Disability (YLDs). Fish is major source of long-chain omega-3 polyunsaturated fatty acids (ω-3 PUFAs) that are important in the development of the central nervous system. Lower ω-3 PUFA levels have been found in red blood cell membranes among depressed people in some studies, but trial evidence that has examined the effect of ω-3 PUFAs on depression is very limited. Objectives: This review aims to find out if there is any association of fish consumption or dietary intake of omega-3 PUFAs with prevalence of depression among adult men and women. Methods: Research articles were searched through database PubMed by using search string “fish consumption AND depression”. The inclusion criteria were being the articles based on studies dealing with omega-3 PUFAs in fish in relation to depression or mood disorders among men and women. Results: Fish consumptions or intake of ω-3 PUFAs were inversely associated with the prevalence of depressive symptoms among men and women. There were gender differences in the results where one study demonstrated the association in men; two studies demonstrated the association in women and one study found association in both men and women. Conclusion: High dietary intakes of fish and omega-3 fatty acids appear to be related to a lower risk of depression in all the studies included in this review, although there is inconsistency with gender.
    International Journal of Medical Research. 12/2013;
  • [show abstract] [hide abstract]
    ABSTRACT: Despite numerous antidepressants available, many patients with depression do not achieve adequeate response rendering needs for novel antidepressants with different mechanism of actions. Acetyl-L-carnitine (ALC) is a potential antidepressant with novel mechanism of action because of its diverse functions related with neuroplasticity. Animal and cellular models suggest that ALC’s neuroplasiticity effect, membrane modulation, and neurotransmitter regulation may play an important role in treatment of depression. Four randomized clinical studies (RCT) demonstrated the superior efficacy of ALC over placebo (PBO) in patients with depression. Two RCTs showed its superior efficacay over PBO in dysthymic disorder, and 2 other RCTs showed that it is equally effective as fluoxetine and amisulpride in treatment of dysthmic disorder. ALC was also effective in improving depressive symptoms in patients with fibromyalgia and minimal hepatic encephalopathy. It was also found to be equally toletable to PBO and better tolerable than fluoxetine and amisulpride. In conclusion, ALC may be potentially effective and tolerable next treatment option with novel action mechanisms for patients with depression, in particular older population and patients with comorbid medical conditions who are vulnerable to adverse events from antidepressants. However, more clinical trial data with adequately-powered, well-designed and advanced methodology will be mandatory to conclude whether ALC as a monotherpay or augmentation agent may be efficacious and clinically beneficial for depression.
    Journal of psychiatric research 01/2014; · 3.72 Impact Factor

Malcolm Peet